|
|
|
20.09.25 - 06:42
|
GST 2.0 rollout: Cheaper essentials hit shelves early; firms pass on rate cuts (Times of India)
|
|
|
Companies are proactively reducing prices on daily essentials as the new, lower GST rates take effect. Major FMCG players like P&G and Hindustan Unilever have already begun dispatching products with revised price tags, absorbing the tax gap to boost buyer sentiment. This move aims to revive consumption and benefit from simplified GST slabs, potentially increasing disposable income for households....
|
|
|
|
|
|
|
18.09.25 - 16:45
|
Wall Street Analysts Think P&G (PG) Is a Good Investment: Is It? (Zacks)
|
|
|
According to the average brokerage recommendation (ABR), one should invest in P&G (PG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?...
|
|
|
|
|
|
|
|
|
|
|
|
|
09.09.25 - 02:24
|
MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor (Business Wire)
|
|
|
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX), “MedX” or the “Company”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist and educator, as Strategic Advisor to the Company.
Dr. Matts joined Procter & Gamble (P&G) in 1988 as a PhD biochemist and then spent more than three decades in the company's Research & Development (R&D) divisions, where he applied his expertise to develop breakthrough measures of skin condition, optics and health. Across his 36 year career, he drove serial innovation across some of P&G's most iconic brands in skin care, colour cosmetics, personal cleansing, hand and body care, and was sought out as a consultant for projects across P&G's other product categories. He retired in 2024 as R&D Vice President and was honoured as a member of P&G's Victor Mills Society, the company's most prestigious recognition for scientific innovat...
|
|
|
|
|
04.09.25 - 16:36
|
Procter & Gamble Aktie: Marken, die wirken - Preise, die halten (Aktiencheck)
|
|
|
Wien (www.aktiencheck.de) - Procter & Gamble-Aktienanalyse der Raiffeisen Bank International AG (RBI):
Andreas Schiller, Analyst der Raiffeisen Bank International AG (RBI), stuft in einer aktuellen Aktienanalyse die Aktie von Procter & Gamble Co. (P&G) (ISIN: US7427181091, WKN: 852062, Ticker-Symbol: PRG, NYSE-Symbol: PG) von "Halten" auf "Kauf" hoch. [mehr]...
|
|
|
|
|
02.09.25 - 22:21
|
P&G Recommends Stockholders Reject Mini-Tender Offer by Tutanota LLC (Business Wire)
|
|
|
CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) today announced that it has been notified of an unsolicited “mini-tender” offer by Tutanota LLC (Tutanota) to purchase up to 500,000 shares of the Company's common stock at a price of $128 per share. The offer is conditioned on, among other things, the closing price per share of P&G stock exceeding $128 on the last trading day before the offer expires. This means that unless this condition is waived by Tutanota, P&G shareholders who tender their shares in the offer will receive a below-market price. Tutanota further states in its offering documents that it expects to extend the offer for successive periods of 45 to 180 days until the market price of the shares exceeds the offer price.
P&G recommends shareholders do not tender their shares in response to this unsolicited mini-tender offer because the offer is at a price below a conditional market price of P&G's shares and is subject to numerous conditions. P&G shareholders who have a...
|
|
|
|
|
|
|
01.09.25 - 12:18
|
Investieren vs. Spekulieren mit Nvidia, Palantir und Novo Nordisk (BRN)
|
|
|
Der Wow-Effekt bei Nvidia blieb letzte Woche aus, obwohl der Chiphersteller mit einem Jahresumsatz von rund 46,7 Mrd. USD und einem Quartalsgewinn von über 26 Mrd. USD die Erwartungen erneut übertraf. Wolfgang Juds, Vermögensverwalter Credo: "Wenn man den Vergleich zieht: Der Chip-Designer aus Santa Clara in Kalifornien ist mittlerweile ungefähr so viel wert wie die 100 größten Konsumwerte der Welt zusammengenommen. Stellen wir uns vor: Unternehmen wie Walmart, Coca-Cola, Nestle, Procter & Gamble, LOreal oder Unilever erzielen zusammen einen Umsatz von etwa 4000 Mrd. Euro, während Nvidia auf das Jahr hochgerechnet rund 140 Mrd. USD umsetzt. Im nächsten Jahr könnten es zwar 200 Mrd. USD werden - aber zwischen 200 Mrd. und 4000 Mrd. liegt immer noch ein gewaltiger Unterschied. Dieser Bewertungsunterschied zeigt, wie viel Fantasie und Euphorie bereits in Nvidia eingepreist ist. - Palantir beispielsweise erzielt einen Umsatz von 3,6 Mrd. USD, hat aber eine Marktkapitalisierung von über 300 Mrd.. Das...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
